Document is current
Any future updates will be listed below
-
Authors
Hongell, Kira https://orcid.org/0000-0002-6371-2107
Silva, Diego G.
Ritter, Shannon
Meier, Daniela Piani
Soilu-Hänninen, Merja
-
Funding
Funding for this research was provided by:
The Cultural Foundation of Åland (2500 EUR)
- License Information
-
More Information
Article History
Received: 10 August 2017
Revised: 28 November 2017
Accepted: 30 November 2017
First Online: 14 December 2017
Compliance with ethical standards
:
: This post hoc analysis and data-mining were funded by Novartis. The corresponding author got financial support from the Cultural Foundation of Åland for drafting of the manuscript.
: The FREEDOMS studies have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons included in these trials have given their informed consent prior to their inclusion in the studies.
: Dr. Kira Hongell has received travel grants and financial funding for participation in international congresses by Novartis, Biogen Idec, Teva and the Finnish Neurological Society, and research funding from the Maire Taponen Foundation and the Cultural Foundation of Åland. Dr. Merja Soilu-Hänninen has obtained lecture fees and travel reimbursements from Bayer, Biogen Idec Finland, Genzyme, Merck, Novartis, Sanofi, Orion and Teva. Diego Silva, Shannon Ritter and Daniela Piani Meier are employees of Novartis.
